The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Dr Jordi Rovira graduated in Biology at the Universitat de Girona and completed his doctoral thesis at the Biochemistry Unit of the Faculty of Medicine from the Universitat de Barcelona. In 2006, he joined the Laboratori Experimental de Nefrologia i Trasplantatment (LENIT) under the direction of Dr Josep M Campistol. He was involved in the evaluation of the pathophysiological mechanisms of proteinuria associated with treatment with inhibitors of the mTOR pathway using experimental models of chronic renal failure and renal transplantation. In addition, he studied some side effects due to treatment with mTOR inhibitors; weight loss, diabetes, anaemia, testicular and pulmonary toxicities. In 2011, he began his postdoctoral stay in the Department of Experimental Surgery at the University Hospital Regensburg led by Dr Edward K Geissler. Dr Rovira was able to learn new experimental models; skin and heart transplantation, warm ischemia in liver and kidney, tumour progression and metastasis models, as well as flow cytometry and cell culture techniques. In April 2013, he returned to LENIT where he implemented all the techniques learned. Since the reincorporation, he has led together with Dr Diekmann several studies in the transplant immunology research field. He is currently involved in the search for new therapeutic strategies to prolong the renal graft survival in both animal models and, as far as possible, in clinical trials.
Dr Rovira has participated in the design and development of studies that include the use of different cell therapies; mesenchymal stromal cells and their extracellular vesicles, tolerogenic dendritic cells, extracorporeal photopheresis (ECP), as well as the generation of cytotoxic T cells with chimeric antigen receptors in kidney transplantation and kidney diseases. Recently, the European consortium for training doctoral students (Horizon-MSCA-2022-DN-01) called “Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation (exTra – 101119855)” has been created. In this context, Dr Diekmann and Dr Rovira will supervise a doctoral student to develop his doctoral thesis on “ECP as add-on therapy in high-risk kidney transplant recipients”.
